Option Care Health, Inc. (NASDAQ:OPCH) Q1 2024 Earnings Call Transcript

The far majority of immunoglobulin patients still receive their therapy intravenously. And so we would expect that and as we’ve articulated. Our therapy mix is quite dynamic and it changes every single year. And so that’s part of the calculus that goes into our outlook, expecting to drive high single digits. Naturally, there’s going to be some patients that migrate towards self-administration that may or may not fall under our clinical model if they require clinical support. But I think you bring up a good point which is, you also have to read the label because some of those newer therapies still require health care professional oversight or training and patient support which still falls well within the sphere of focus for this enterprise. So that’s nothing new.

It’s something that we fully expect going forward as we think about the top line and it’s something that we’re staying one step ahead of through our trade relations effort.

John Rademacher: And the only thing I’d add, Joanna, is and that’s part of the build out of the infusion suites as well is just to make certain that we’re well positioned to meet the needs of those patients, especially if you’re moving towards shorter duration administration through some of those products that require health care professional oversight.

Operator: And I’m showing no further questions. I would now like to turn the conference back to management for closing remarks.

John Rademacher: Great. Thank you all for joining us this morning and participating on our call. As we outlined, the first quarter was a very productive quarter and our team continued to execute at a very high level even with significant disruptions in the marketplace. We understand the important role that we play in delivering care to our patients and their family. And this remains a light that guides us as we continue on our path to serve even more patients in 2024. Take care and have a great day. Thank you, everyone.

Operator: And this concludes today’s conference call. Thank you for participating. You may now disconnect.